|
||||||||
Media Home | Contact Us |
|
January 21, 2000 The Centers for Disease Control and Prevention (CDC) today announced the 2000 childhood
immunization schedule, which includes changes made during the last year that ensure
vaccinations for the Nation's children remain safe and effective. The new schedule appears in
the January 21, 2000, issue of CDC's Morbidity and Mortality Weekly Report.
The changes in the schedule, proposed by CDC's Advisory Committee on Immunization Practices
(ACIP), recommend the use of inactivated poliovirus vaccine (IPV) alone for routine childhood
polio vaccination, remove rotavirus vaccine from the schedule, and recommend exclusive use of
acellular pertussis (whooping cough) vaccines for all doses of the pertussis vaccine series.
In addition, hepatitis A (Hep A) vaccination is now recommended for use in selected areas of
the United States with high rates of hepatitis A. The American Academy of Pediatrics and the
American Academy of Family Physicians have made the same recommendations regarding the
childhood immunization schedule.
"Vaccines are among the safest and most successful public health tools available for
preventing diseases and death," said Walter A. Orenstein, M.D., Director of the CDC's
National Immunization Program. "The changes in the recommendations for polio and
pertussis vaccinations and the removal of rotavirus vaccine from the schedule reflect our
ongoing commitment to protecting our children's health with safe and effective vaccines.
Childhood vaccination levels in the United States are at an all-time high, and disease and
death from diphtheria, pertussis, tetanus, measles, mumps, rubella and Haemophilus
influenzae type b are at or near record lows. For instance, provisional data indicate
there was only one reported case of diphtheria, 86 reported cases of measles, and no reported
cases of wild poliovirus for 1999. Nonetheless, about 20 percent of American toddlers remain
vulnerable to disease because they are not fully immunized.
Under the updated schedule, IPV is now the only polio vaccine recommended for routine use
in the United States. The recommendation to use an all-IPV schedule for routine childhood
polio vaccination will eliminate the rare occurrence of vaccine-associated paralytic
poliomyelitis (VAPP) in the United States. All children should receive four doses of IPV at 2
months, 4 months, between 6-18 months, and 4-6 years. Since 1979, the only cases of polio in
the United States have been caused by the oral poliovirus vaccine. The risk of VAPP from the
oral polio vaccine is about one case in every 2.4 million doses. There have been no reported
cases of vaccine-associated paralytic poliomyelitis from IPV.
The decision to remove rotavirus vaccine from the schedule was based on results of an
expedited review by CDC of scientific data that indicated an association between the rotavirus
vaccine and intussusception, a form of bowel obstruction, among some infants during the first
one to two weeks following vaccination. Use of the rotavirus vaccine was suspended in July,
and on October 22, 1999, the ACIP recommended that the vaccine no longer be used in the United
States. Children who received rotavirus vaccine before July are no longer at risk for
intussusception from the vaccine.
"We are committed to ongoing monitoring and to ensuring vaccine safety," said Dr.
Orenstein. "While no drug, and no vaccine, is 100 percent safe, the serious adverse
events that do occur following vaccination are extremely rare. The public is entitled to and
should expect safe and effective vaccines. We are constantly striving to ensure vaccines are
safe and effective so our children will have a healthy start to life."
A third change makes acellular pertussis vaccines the only recommended pertussis vaccine
for all doses. Whole-cell pertussis vaccines are no longer recommended for use. Acellular
pertussis vaccines are recommended because they are less likely to cause the adverse reactions
that have been associated with the whole-cell pertussis vaccines. All children should receive
diphtheria, tetanus, and acellular pertussis (DTaP) vaccine at 2 months, 4 months, 6 months,
between 15 and 18 months, and between 4 and 6 years. Subsequent routine tetanus-diphtheria
boosters are recommended every ten years
The fourth change in the recommended childhood schedule will protect more children from
hepatitis A, an infectious disease of the liver. The new schedule recommends vaccination of
children living in States with consistently high rates of hepatitis A. Since hepatitis A
vaccination is not recommended throughout the United States, parents should talk with their
healthcare provider or local public health authority to find out about current recommendations
for their community.
As part of ongoing efforts to continually improve vaccine safety, the CDC and other
Department of Health and Human Services agencies will also be directing additional resources
to vaccine safety initiatives in the coming year. These initiatives include enhancements to
the Vaccine Adverse Event Reporting System, improvements in educational materials, and
enhanced efforts to determine whether adverse reactions reported after vaccination are
causally related or coincidental through independent expert reviews of available information.
The NIP and others will also continue expansion of research designed to identify uncommon
vaccine side effects.
|
CDC Home | Search | Health Topics A-Z This page last reviewed Friday, January 21, 2000 |